Tanaav Shant Tablet in Stress

To evaluate the efficacy of Tanaav Shant Tablet in Stress Disorder

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024555

Enrollment

Registered

2020-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F418- Other specified anxiety disorders

Interventions

Intervention1: Tanaav Shant Tablet: Tanaav Shant Tablet oral 2 tablet at bed time with luke warm water for 45 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: •Classical symptoms of stress, anxiety, insomnia, restlessness and mental fatigue. •Without any complication.

Exclusion criteria

Exclusion criteria: •Age group 60 years. •Any other chronic illness. •Addicted to alcohol.

Design outcomes

Primary

Measure	Time frame
ImprovementTimepoint: 45 days	—

Secondary

Measure	Time frame
ImprovementTimepoint: 45 days	—

Countries

India

Contacts

Public ContactZeba Malik

Rishikul Ayurvedic College Haridwar Uttarakhand

dr.opsingh63@gmail.com9411503035

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026